BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 212482)

  • 21. Comparison of radioimmunoassay for internal protein of bovine leukemia virus with neutralization test employing VSV-BLV pseudotype.
    Zajac V; Altaner C; Závada J; Cerný L
    Neoplasma; 1980; 27(5):517-23. PubMed ID: 6262669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antigens of vesicular stomatitis virus. I. Separation and immunogenicity of three complement-fixing components.
    Brown F; Cartwright B; Almeida JD
    J Immunol; 1966 Mar; 96(3):537-45. PubMed ID: 4286685
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of an enzyme-linked immunosorbent assay for detection of antibodies to vesicular stomatitis virus in cattle in an enzootic region of Mexico.
    Hernández De Anda J; Salman MD; Webb PA; Keefe TJ; Arregín Arévalo A; Mason J
    Am J Vet Res; 1992 Apr; 53(4):440-3. PubMed ID: 1316723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serological characterization of the three major proteins of vesicular stomatitis virus.
    Dietzschold B; Schneider LG; Cox JH
    J Virol; 1974 Jul; 14(1):1-7. PubMed ID: 4365717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A vesicular stomatitis virus (cytomegalovirus) pseudotype and its use in neutralization tests.
    Vonka V; Závadová H; Poláková D
    Intervirology; 1979; 12(1):32-8. PubMed ID: 227814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional Dissection of the Dominant Role of CD55 in Protecting Vesicular Stomatitis Virus against Complement-Mediated Neutralization.
    Asok Kumar N; Muraleedharan Suma S; Kunnakkadan U; Nag J; Koolaparambil Mukesh R; Lyles DS; Johnson JB
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33652918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative performance of four serodiagnostic procedures for detecting bovine and equine vesicular stomatitis virus antibodies.
    Katz JB; Eernisse KA; Landgraf JG; Schmitt BJ
    J Vet Diagn Invest; 1997 Jul; 9(3):329-31. PubMed ID: 9249179
    [No Abstract]   [Full Text] [Related]  

  • 28. Production of neutralizing antibody to rabies and vesicular stomatitis viruses by hybrid cell lines.
    Sethi KK; Brandis H
    Cell Immunol; 1980 Feb; 49(2):260-5. PubMed ID: 6243514
    [No Abstract]   [Full Text] [Related]  

  • 29. Surface structure of vesicular stomatitis virus.
    Cartwright B; Smale CJ; Brown F
    J Gen Virol; 1969 Jul; 5(1):1-10. PubMed ID: 4309923
    [No Abstract]   [Full Text] [Related]  

  • 30. Kinetic and affinity limits on antibodies produced during immune responses.
    Foote J; Eisen HN
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1254-6. PubMed ID: 7877964
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence for a host cell component in vesicular stomatitis virus.
    Cartwright B; Pearce CA
    J Gen Virol; 1968 Mar; 2(2):207-14. PubMed ID: 4297603
    [No Abstract]   [Full Text] [Related]  

  • 32. COCAL VIRUS, A NEW AGENT IN TRINIDAD RELATED TO VESICULAR STOMATITIS VIRUS, TYPE INDIANA.
    JONKERS AH; SHOPE RE; AITKEN TH; SPENCE L
    Am J Vet Res; 1964 Jan; 25():236-42. PubMed ID: 14103231
    [No Abstract]   [Full Text] [Related]  

  • 33. Neutralization of Mason-Pfizer virus by sera from patients treated for renal disease.
    Thiry L; Sprecher-Goldberger S; Bossens M; Cogniaux-Le Clerc J; Vereerstraeten P
    J Gen Virol; 1978 Dec; 41(3):587-97. PubMed ID: 217951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement components required for virus neutralization by early immunoglobulin antibody.
    Linscott WD; Levinson WE
    Proc Natl Acad Sci U S A; 1969 Oct; 64(2):520-7. PubMed ID: 4982356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo interference in vesicular stomatitis virus infection.
    Crick J; Brown F
    Infect Immun; 1977 Feb; 15(2):354-9. PubMed ID: 191397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation and biologic role of polyoma virus-antibody complexes. A critical role for complement.
    Oldstone MB; Cooper NR; Larson DL
    J Exp Med; 1974 Aug; 140(2):549-65. PubMed ID: 4367757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-mediated neutralization of virus is abrogated by mycoplasma.
    Dickson C; Elkington J; Hales A; Weiss R
    Infect Immun; 1980 Jun; 28(3):649-53. PubMed ID: 6249748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and serological response to laboratory-acquired human infection by Indiana type vesicular stomatitis virus (VSV).
    Johnson KM; Vogel JE; Peralta PH
    Am J Trop Med Hyg; 1966 Mar; 15(2):244-6. PubMed ID: 4286381
    [No Abstract]   [Full Text] [Related]  

  • 39. Coliphage T2 neutralization by 7S antibody and C1.
    Schrader JA; Muschel LH
    Immunochemistry; 1975 Oct; 12(10):791-4. PubMed ID: 812797
    [No Abstract]   [Full Text] [Related]  

  • 40. The complement system: its importance in the host response to viral infection.
    Hirsch RL
    Microbiol Rev; 1982 Mar; 46(1):71-85. PubMed ID: 7045625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.